Erythritol

Several papers since February 2023 have linked higher circulating erythritol with major adverse cardiovascular events. The Cleveland Clinic Nature Medicine paper also reported platelet and thrombosis effects in lab models, and 2025 cohort work in ARIC and the Nurses' Health Study found similar observational associations. That is enough to treat the signal as real, not internet fiction. But it is still not proof that eating erythritol causes heart attacks: those studies mostly measured blood erythritol, not diet, and high circulating levels also track diabetes, kidney impairment, and endogenous erythritol production.

Across small human crossover and short-duration trials, erythritol has shown little to no acute effect on glucose or insulin compared with water, and much smaller responses than sucrose or glucose. That is why it is popular in lower-sugar and diabetes-focused products. The catch is scope: most studies are small, short, and designed around metabolic responses over hours or days, not long-term clinical outcomes. So it is fair to say erythritol is near-zero-glycemic in acute use; it is not yet fair to say that makes heavy long-term use broadly beneficial.

Erythritol is usually better tolerated than sorbitol or xylitol because most of it is absorbed in the small intestine and excreted unchanged in urine. Even so, large bolus doses can cause nausea, borborygmi, bloating, or diarrhea, and tolerance varies by body size and what else is eaten with it. Dose-ranging and tolerance studies generally find everyday product-level amounts are less troublesome than other polyols, while 25-50 g taken quickly is where symptoms become more noticeable for some people. So the digestive-risk story is real, but it is mainly a high-dose issue rather than proof that normal use is inherently harmful.

Mechanistic studies make erythritol look interesting: intragastric test solutions have increased CCK, GLP-1, and PYY and slowed gastric emptying without raising glucose or insulin. That sounds like a satiety advantage. But when researchers tested actual meal replacement with erythritol versus sucrose, subsequent food intake and gut-hormone responses were not clearly better. In other words, the physiology signal exists, but it has not translated cleanly into people reliably eating less. That keeps this in the mixed category rather than evidence that erythritol meaningfully suppresses appetite in everyday diets.

If erythritol replaces sugar in a drink, dessert, or yogurt, the product usually delivers fewer digestible calories and less glycemic load. Broader meta-analyses on low-calorie sweeteners support modest calorie reduction and weight-control benefit when these sweeteners substitute for sugar, especially in beverages. What is missing is strong long-term evidence showing erythritol itself produces meaningful weight loss independent of the substitution. It is a tool, not a metabolic hack. Swapping sugar for erythritol can be useful; adding erythritol-sweetened snacks on top of an already calorie-dense diet is a different story.

Compared with sucralose, emulsifiers, or fermentable fibers, the evidence base for erythritol and the gut microbiome is thin. A big reason is pharmacokinetics: most erythritol is absorbed before it reaches the colon, so there is less substrate available for gut fermentation than with many other sugar alcohols. That does not prove zero microbiome effect in every circumstance, and stronger human data would be welcome. But current claims that erythritol clearly "wrecks the gut" run ahead of the actual human evidence.

Erythritol is one of the few sweeteners with reasonably good oral-health data. In a 3-year randomized trial in schoolchildren, erythritol candies were associated with slower caries development and less dentin-caries progression than comparison candies. That makes sense because oral bacteria do not use erythritol the way they use ordinary sugars. The practical limit is that dental benefit is not the same as whole-body benefit: a tooth-friendly sweetener can still sit inside an ultra-processed product, and caries outcomes do not resolve the newer cardiovascular debate. Still, this is a real upside that often gets lost in all-bad or all-good arguments.

For most people, the first question is not "erythritol yes or no?" but what it is replacing and how much sweetened food the overall diet contains. Replacing several sugary drinks or sweets with erythritol-sweetened versions can reduce sugar exposure; building a diet around ultra-processed keto bars, syrups, and desserts is still a highly sweet, highly engineered pattern. The cardiovascular papers also remind us that high erythritol exposure may cluster with metabolic disease, kidney issues, or heavy sweetener use more broadly. Least Processed's practical read is that erythritol may matter at the margins, but the whole dietary pattern and total sweet-product load matter more.